SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

GeoVax Labs, Inc.
Date: June 25, 2025 · CIK: 0000832489 · Accession: 0001437749-25-021232

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-288085

Date
June 25, 2025
Author
Mark W. Reynolds
Form
CORRESP
Company
GeoVax Labs, Inc.

Letter

govx20250625_corresp.htm

GeoVax Labs, Inc.

1900 Lake Park Drive

Suite 380

Smyrna, Georgia 30080

(678) 384-7220

June 25, 2025

VIA EDGAR

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

Re:

GeoVax Labs, Inc.

Registration Statement on Form S-1

File No. 333-288085

Ladies and Gentlemen:

Reference is made to (i) the letter (the “Company Letter”) dated June 17, 2025, as amended, from GeoVax Labs, Inc., a Delaware corporation (the “Registrant”), to the Division of Corporation Finance whereby the Registrant requested effectiveness of the above-captioned registration statement. The Registrant hereby withdraws the request set forth in the Company Letter.

If you have any questions or comments, please contact me or if you prefer, you may contact our counsel, F. Reid Avett of Womble Bond Dickinson (US) LLP, by telephone at (202) 857-4425, or by email at reid.avett@wbd-us.com.

Very truly yours,
GeoVax Labs, Inc.

Show Raw Text
CORRESP
 1
 filename1.htm

 govx20250625_corresp.htm

 GeoVax Labs, Inc.

 1900 Lake Park Drive

 Suite 380

 Smyrna, Georgia 30080

 (678) 384-7220

 June 25, 2025

 VIA EDGAR

 Division of Corporation Finance

 U.S. Securities and Exchange Commission

 100 F Street N.E.

 Washington, D.C. 20549

 Re:

 GeoVax Labs, Inc.

 Registration Statement on Form S-1

 File No. 333-288085

 Ladies and Gentlemen:

 Reference is made to (i) the letter (the “Company Letter”) dated June 17, 2025, as amended, from GeoVax Labs, Inc., a Delaware corporation (the “Registrant”), to the Division of Corporation Finance whereby the Registrant requested effectiveness of the above-captioned registration statement. The Registrant hereby withdraws the request set forth in the Company Letter.

 If you have any questions or comments, please contact me or if you prefer, you may contact our counsel, F. Reid Avett of Womble Bond Dickinson (US) LLP, by telephone at (202) 857-4425, or by email at reid.avett@wbd-us.com.

 Very truly yours,

 GeoVax Labs, Inc.

 By:

 /s/ Mark W. Reynolds

 Mark W. Reynolds

 Chief Financial Officer